文献速递血栓与止血

他克莫司预防免疫性血小板减少症患者间充质干细胞中补体介导的Nod样受体家族pyrin结构域包含3(NLRP3)炎症小体活化及细胞焦亡

Tacrolimus prevents complement-mediated Nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome activation and pyroptosis of mesenchymal stem cells from immune thrombocytopenia.
PubMed 文献 · Br J Haematol · 2022-12-22

研究探讨补体沉积的免疫性血小板减少症(ITP)骨髓间充质干细胞(MSCs)中NLRP3炎症小体活化及焦亡机制,并评估他克莫司的干预作用。结果显示补体沉积的ITP MSCs发生NLRP3炎症小体活化和caspase-1依赖性焦亡,他克莫司在体外和体内抑制该过程;他克莫司联合达那唑在糖皮质激素抵抗ITP患者中持续缓解率高于达那唑单药。

要点

  • 补体沉积的ITP MSCs中NLRP3炎症小体活化并引发caspase-1依赖性焦亡。
  • 他克莫司在体外和体内抑制NLRP3炎症小体活化及MSCs焦亡。
  • 他克莫司联合达那唑在糖皮质激素抵抗ITP患者中持续缓解率高于达那唑单药。

核心结论

  • 补体介导的ITP MSCs中NLRP3炎症小体活化可被他克莫司抑制,可能成为ITP的潜在新疗法。

研究设计与样本

  • 研究纳入ITP患者骨髓MSCs,比较补体沉积(MSCs-C+)与未沉积MSCs,并行转录组测序。
  • 体外和体内实验评估他克莫司对NLRP3炎症小体活化及MSCs-C+焦亡的影响。
  • 临床试验比较他克莫司联合达那唑与达那唑单药在糖皮质激素抵抗ITP患者中的疗效。

主要发现

  • 补体沉积的ITP MSCs中NLRP3炎症小体活化并启动caspase-1依赖性焦亡。
  • 转录组测序显示MSCs-C+脂肪酸代谢异常,脂肪酸β氧化增强和活性氧产生激活NLRP3炎症小体。
  • MSCs-C+来源脂肪细胞分泌脂联素减少,脂联素促进巨核细胞分化并抑制血小板破坏。
  • 他克莫司在体外和体内抑制NLRP3炎症小体活化及MSCs-C+焦亡。
  • 他克莫司联合达那唑在糖皮质激素抵抗ITP患者中持续缓解率高于达那唑单药。

关键数值与推荐

  • 他克莫司联合达那唑在糖皮质激素抵抗ITP患者中持续缓解率高于达那唑单药(原文未报告具体数值)。

临床怎么用

  • 作者认为他克莫司抑制补体介导的ITP MSCs中NLRP3炎症小体活化,可能是ITP的潜在新疗法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The abnormal immunomodulatory functions of mesenchymal stem cells (MSCs) have been implicated in the development of immune thrombocytopenia (ITP). Recent studies have suggested important effects of complement on immune cell function. However, whether complement modulates bone marrow MSCs function in ITP is poorly defined. Tacrolimus has recently been applied to the treatment of autoimmune diseases. Here, we explored whether impaired ITP-MSCs could be targeted by tacrolimus. Our results showed that the Nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome was activated in ITP MSCs with complement deposition (MSCs-C+ ) and initiated caspase-1-dependent pyroptosis. Transcriptome sequencing results showed abnormal fatty acid metabolism in MSCs-C+ . Enhanced fatty acid β-oxidation and reactive oxygen species production activated the NLRP3 inflammasome. Adipocytes derived from MSCs-C+ secreted less adiponectin. Adiponectin promoted the differentiation of megakaryocytes and inhibited the destruction of platelets. Tacrolimus inhibited NLRP3 inflammasome activation and MSCs-C+ pyroptosis in vitro and in vivo. Tacrolimus plus danazol elicited a higher sustained response than danazol monotherapy in corticosteroid-resistant patients with ITP. Our findings demonstrate that the activation of the NLRP3 inflammasome in ITP MSCs mediated by complement could be inhibited by tacrolimus, which might be a potential new therapy for ITP.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Cai X, Wu J, An ZY, et al. Tacrolimus prevents complement-mediated Nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome activation and pyroptosis of mesenchymal stem cells from immune thrombocytopenia. Br J Haematol. 2022. PMID: 36546515. doi:10.1111/bjh.18625

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。